Showing results (461-470 of 489) with videos related to
Sort By:
Pageof 49
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
A sulfated carbohydrate epitope inhibits axon regeneration after injuryJoshua M Brown, Jiang Xia, BinQuan Zhuang, et al.Scientific Reports|March 16, 2016
Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressorsMohamed El-Far, Pascale Kouassi, Mohamed Sylla, et al.Nature Chemical Biology|March 20, 2012
LYP inhibits T-cell activation when dissociated from CSKTorkel Vang, Wallace H Liu, Laurence Delacroix, et al.The Journal of Biological Chemistry|December 1, 2016
Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2Paula Giménez-Mascarell, Iker Oyenarte, Serge Hardy, et al.Molecular Cancer Research : MCR|June 27, 2020
Elevated V-ATPase Activity Following PTEN Loss Is Required for Enhanced Oncogenic Signaling in Breast CancerAmro H Mohammad, Sung-Hoon Kim, Nicholas Bertos, et al.Science Signaling|April 19, 2022
Protein tyrosine phosphatase 1B regulates miR-208b-argonaute 2 association and thyroid hormone responsiveness in cardiac hypertrophyGérald Coulis, Avinash D Londhe, R Sudheer Sagabala, et al.Immunity|August 2, 2015
Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic CellsAnna Bunin, Vanja Sisirak, Hiyaa S Ghosh, et al.Ear and Hearing|June 30, 2016
Hearing Impairment and Cognitive Energy: The Framework for Understanding Effortful Listening (FUEL)M Kathleen Pichora-Fuller, Sophia E Kramer, Mark A Eckert, et al.Nature Communications|October 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrenceYu Gu, Tarek Taifour, Tung Bui, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2020
4E-BP-Dependent Translational Control of Irf8 Mediates Adipose Tissue Macrophage Inflammatory ResponseDana Pearl, Sakie Katsumura, Mehdi Amiri, et al.Pageof 49